Use of statins offsets insulin-related cancer risk.

Kautzky-Willer, A; Thurner, S; Klimek, P

Kautzky-Willer, A; Thurner, S; Klimek, P.

Affiliation

Kautzky-Willer A; Gender Medicine Unit, Endocrinology & Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Thurner S; Section for Science of Complex Systems, CEMSIIS, Medical University of Vienna, Vienna, Austria.
Klimek P; Santa Fe Institute, Santa Fe, NM, USA.

J Intern Med ; 281(2): 206-216, 2017 02.

Article in En | MEDLINE | ID: mdl-27766700

Subject(s)

Diabetes Mellitus, Type 2/epidemiology; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Hypoglycemic Agents/adverse effects; Insulin/adverse effects; Neoplasms/epidemiology; Austria/epidemiology; Comorbidity; Diabetes Mellitus, Type 2/complications; Female; Humans; Hyperglycemia/complications; Male; Neoplasms/complications; Prevalence; Regression Analysis; Risk Factors; Sex Distribution

Key words

epidemiology; insulin therapy; medical claims data; oral antihyperglycaemic agents; site-specific cancer risks; statin therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Diabetes Mellitus, Type 2 / Hypoglycemic Agents / Insulin / Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Prevalence_studies / Risk_factors_studies Limits: Female / Humans / Male Country/Region as subject: Europa Language: En Journal: J Intern Med Journal subject: MEDICINA INTERNA Year: 2017 Type: Article Affiliation country: Austria

Fulltext

XML

PubMed Links

Search on Google